Several studies have shown that combinations of TSG mutations/allele deletions (tumour protein p53 (TP53), Neurofibromatosis type 1 (NF1), PTEN and RB1) in the NSCs of mouse models lead to the development of high-grade glioma [168,169,170,171]. This evidence concerns the gene RB1 and central nervous system cancer.